- Home
- ADAG vs GEG Comparison
ADAG vs GEG Comparison
Compare ADAG & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAG | GEG |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 80.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADAG | GEG |
|---|---|---|
| Price | $1.58 | $2.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 50.9K | ★ 83.4K |
| Earning Date | 08-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $103,204.00 | ★ $23,112,000.00 |
| Revenue This Year | $6,983.06 | N/A |
| Revenue Next Year | $36.05 | N/A |
| P/E Ratio | ★ N/A | $21.17 |
| Revenue Growth | N/A | ★ 24.82 |
| 52 Week Low | $1.30 | $1.76 |
| 52 Week High | $3.16 | $3.51 |
Technical Indicators
Market Signals| Indicator | ADAG | GEG |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 41.72 |
| Support Level | $1.50 | $2.37 |
| Resistance Level | $1.83 | $2.55 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 31.40 | 22.73 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.